Sort
8,912 grants matching “sars cov 2”
Molecularly Engineered Lectins for Intranasal Prophylaxis and Treatment of Coronaviruses
$728,193David Michael Markovitz · University Of Michigan At Ann Arbor · R01 · FY2023 · AI
Linking SARS-CoV-2 Aerosol Viability and Environmental Factors in Healthcare Settings
$728,176Kerry Kelly · University Of Utah · R01 · FY2024 · AI
Human coronavirus infection of the nasal epithelium
$727,886Susan R. Weiss · University Of Pennsylvania · R01 · FY2022 · AI
Research Employing Environmental Systems and Occupational Health Policy Analyses to Interrupt the Impact of Structural Racism on Agricultural Workers and Their Respiratory Health (RESPIRAR)
$727,806Devon C Payne-Sturges · Univ Of Maryland, College Park · R01 · FY2023 · ES
Improving Glycemia & Reducing Diabetes Distress in Adolescents & Young Adults with T1D
$727,742Lori M Laffel · Joslin Diabetes Center · R01 · FY2021 · DK
Developing a Multi-epitope Pan-Coronavirus Vaccine
$727,670Lbachir Benmohamed · University Of California-Irvine · R01 · FY2024 · AI
Endothelial Cell and Cardiomyocyte Dysfunction in Children with Kawasaki disease-like SARS-CoV-2 Induced Immune Activation
$727,650Jane C Burns · University Of California, San Diego · R01 · FY2020 · HL
Epitope dynamics and functional analysis of viral envelope glycoprotein by cryo-electron tomography and single particle cryo-EM
$727,531Mario Borgnia · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Analysis of immunologic mechanisms in patients with chronic lung disease after acute COVID infection
$727,528Homer L Twigg · Indiana University Indianapolis · R01 · FY2025 · HL
Project 2: Characterizing humoral responses to SARS-CoV-2, and the immunological and biological effects of plasma therapy for severe Covid-19
$727,058Luther A Bartelt · Univ Of North Carolina Chapel Hill · U54 · FY2020 · CA
Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in blood
$726,852Tony Y. Hu · Tulane University Of Louisiana · R01 · FY2024 · AI
SARS-COV-2 Sequence Surveillance: Molecular Epidemiology, Clinical Correlations and Prospective Monitoring
$726,666John P. Kirwan · Lsu Pennington Biomedical Research Ctr · U54 · FY2022 · GM
Advancing the development of a novel class of small molecules for treating pan-coronavirus infections
$726,503Shirit Einav · Stanford University · R01 · FY2024 · AI
Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2
$726,465Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2024 · HL
Project 1: Immune Memory
$726,394Rafi Ahmed · Emory University · U19 · FY2022 · AI
Ultrafast Biophysical Studies of Biomolecules at the APS
$726,073Philip Anfinrud · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
A Tunable Nanophage Platform for Vaccine Development
$726,000Carlos Enrique Catalano · University Of Colorado Denver · R56 · FY2024 · AI
Immunoengineering
$725,967Kaitlyn Sadtler · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2021 · EB
Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy
$725,845Pamela Tinmoi Wong · University Of Michigan At Ann Arbor · R01 · FY2024 · AI
Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
$725,783Alexander Misharin · Northwestern University At Chicago · R01 · FY2024 · HL
Emetine for SARS-CoV-2
$725,728Mark Henderson · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)
$725,727Marco Salemi · University Of Florida · R01 · FY2025 · AI
When are in-person HIV services worth the risk of COVID-19 and other communicable illnesses? Optimizing choices when virtual services are less effective
$725,525Anna Bershteyn · New York University School Of Medicine · R01 · FY2023 · MH
Regulation of inflammatory gene expression during SARS2 infection
$725,413Ivan Marazzi · University Of California-Irvine · R01 · FY2025 · AI
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
$725,409Dan H. Barouch · Beth Israel Deaconess Medical Center · U01 · FY2022 · CA